GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (STU:V9G0) » Definitions » Cyclically Adjusted PS Ratio

XWELL (STU:V9G0) Cyclically Adjusted PS Ratio : 0.00 (As of Jun. 10, 2024)


View and export this data going back to 2012. Start your Free Trial

What is XWELL Cyclically Adjusted PS Ratio?

As of today (2024-06-10), XWELL's current share price is €2.96. XWELL's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €2,210.00. XWELL's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for XWELL's Cyclically Adjusted PS Ratio or its related term are showing as below:

During the past years, XWELL's highest Cyclically Adjusted PS Ratio was 0.19. The lowest was 0.01. And the median was 0.02.

STU:V9G0's Cyclically Adjusted PS Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.4
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

XWELL's adjusted revenue per share data for the three months ended in Mar. 2024 was €1.919. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €2,210.00 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


XWELL Cyclically Adjusted PS Ratio Historical Data

The historical data trend for XWELL's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XWELL Cyclically Adjusted PS Ratio Chart

XWELL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 0.03 0.01 -

XWELL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - - -

Competitive Comparison of XWELL's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, XWELL's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XWELL's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, XWELL's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where XWELL's Cyclically Adjusted PS Ratio falls into.



XWELL Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

XWELL's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.96/2210
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XWELL's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, XWELL's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.919/131.7762*131.7762
=1.919

Current CPI (Mar. 2024) = 131.7762.

XWELL Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 84.143 100.560 110.264
201409 14.500 100.428 19.026
201412 22.750 99.070 30.261
201503 17.375 99.621 22.983
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 2,068.900 99.792 2,731.989
201603 153.000 100.470 200.674
201606 841.833 101.688 1,090.920
201609 212.538 101.861 274.958
201612 -327.538 101.863 -423.724
201703 647.750 102.862 829.829
201706 719.063 103.349 916.848
201709 539.150 104.136 682.256
201712 459.364 104.011 581.988
201803 486.619 105.290 609.033
201806 507.318 106.317 628.804
201809 461.417 106.507 570.892
201812 349.586 105.998 434.604
201903 349.161 107.251 429.006
201906 346.182 108.070 422.122
201909 237.042 108.329 288.347
201912 37.833 108.420 45.983
202003 22.245 108.902 26.918
202006 0.065 108.767 0.079
202009 0.056 109.815 0.067
202012 0.057 109.897 0.068
202103 1.415 111.754 1.669
202106 1.432 114.631 1.646
202109 4.294 115.734 4.889
202112 4.838 117.630 5.420
202203 4.298 121.301 4.669
202206 2.698 125.017 2.844
202209 2.292 125.227 2.412
202212 1.717 125.222 1.807
202303 1.583 127.348 1.638
202306 1.809 128.729 1.852
202309 1.677 129.860 1.702
202312 1.621 129.419 1.651
202403 1.919 131.776 1.919

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


XWELL  (STU:V9G0) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


XWELL Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of XWELL's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


XWELL (STU:V9G0) Business Description

Traded in Other Exchanges
Address
254 West 31st Street, 11th Floor, New York, NY, USA, 10001
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

XWELL (STU:V9G0) Headlines

No Headlines